Immune Checkpoint Inhibitors Lead the Bladder Cancer Treatment Drugs Market with US$ 14.8 Billion in Revenue by 2033: Persistence Market Research New York, March 28, 2023 (GLOBE NEWSWIRE) -- As per this new industry analysis by Persistence Market Research, the global Bladder Cancer Treatment Drugs Market was valued at US$ 3.04 billion in 2022...

Bladder Cancer Treatment Drugs Market is estimated to surge to US$ 11.5 Bn by 2032 – Persistence Market Research New York, Oct. 20, 2022 (GLOBE NEWSWIRE) -- North America is expected to capture the largest share of the global bladder cancer treatment drugs market and retain the same throughout the forecast...